OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 14, 2021
Avid Bioservices is building a viral vector development and manufacturing facility near its existing biologics manufacturing facility in California.
October 04, 2021
Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.
October 02, 2021
The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.
September 02, 2021
Advancements in bioprocessing technologies test microbial fermentation adaptability.
September 01, 2021
Avantor plans to address rising global demand for biologics with their investment in hydration capabilities.
August 25, 2021
AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 17, 2021
Syngene’s additions include a new microbial facility and an expanded mammalian facility.
August 13, 2021
PNI expands global headquarters with a new 75,000-square-foot facility, which will include multiple GMP suites for manufacturing RNA therapeutics and vaccines.
Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules.